baber/WOPTO huggingface dataset:
Patent MX-2007003196-A (MX)
Title: Agent and food for preventing/improving functional digestive disorder.
Inventor: UNEYAMA HISAYUKI
IPC: A23L27/23
Filed: 2005-09-16
Abstract: It is intended to provide an agent and a food for preventing/improving functional digestive disorder which contains, as the active ingredient, at least one member selected from among glutamic acid, 5 -nucleotides and salts thereof.
Patent MX-2007004686-A (MX)
Title: Multidomain rna molecules comprising at least one aptamer for delivering double stranded rna to pest organisms.
Inventor: PLAETINCK GEERT
IPC: A01H5/00
Filed: 2005-10-25
Abstract: The present invention relates to methods and constructs for delivering double stranded RNA (dsRNA) to pest organisms. More specific, the invention relates to a multidomain RNA molecule consisting of a nucleotide sequence comprising (i) at least one aptamer and (ii) at least one nucleotide sequence of interest forming double-stranded RNA, said double-stranded RNA comprising annealed complementary strands, one of which comprises a nucleotide sequence which is complementary to at least part a pest target nucleotide sequence. The invention further relates to nucleic acids encoding the multidomain RNA molecules and to various uses of the multidomain RNA molecules in agriculture.
Patent MX-2007007569-A (MX)
Title: Solid pharmaceutical compositions.
Inventor: BECKER DIETER
IPC: A61K9/00
Filed: 2005-12-20
Abstract: A solid pharmaceutical composition comprising a poorly water soluble drug,a polymer which is solid at room temperature, and a disintegrant in an amount of less than 10% by weight, wherein the amounts by weight are based on the total weight of the composition.
Patent MX-2007008881-A (MX)
Title: Applicator for inserting an implant.
Inventor: TAK MAURICE PETRUS WILHELMUS
IPC: A61M37/00
Filed: 2006-01-20
Abstract: The invention pertains to an applicator (1) for inserting an implant, in particular a rod-like implant (2) containing an active substance, under the skin of a human or animal, comprising a housing (3), a cannula (6) extending from the housing (3), and a handle (15) for grasping and manoeuvring the applicator (1) and the cannula (6) during insertion of an implant (2). In accordance with the invention, the handle (15) extends above at least part of the length of the cannula (6). Such a handle facilitates insertion of the cannula and/or accurate positioning of the implant.
Patent MX-2007010639-A (MX)
Title: Multipart plastic closure.
Inventor: MATHIS LORENZ
IPC: B65D90/64
Filed: 2006-03-01
Abstract: Disclosed is a multipart plastic closure that is designed so as to absorb an elevated internal pressure in the container on which the closure is mounted while avoiding deformations affecting the tightness of the closure. Said multipart plastic closure is composed of a bottom part (1) that is provided with a first region with an outer surface (11) and an internal thread in order to screw the closure onto a container while being closed at the top with the aid of a spout (18). The spout (18) is equipped with a covering area (21) which is reduced as an annular sealing area (38) and is reinforced using stiffening means (23). A central spout (22) is provided with sealing means (24) while a sealing plug (29) which is molded onto the bottom face of an attachable screw cap (2) penetrates into said central spout (22). One or several drinking holes (28) are molded into the covering area (27) in the region of the outer wall (25) of the screw cap (2) and the sealing plug (29). The inventive multipart plastic closure is able to seal also relatively great internal pressures in the container.
Patent MX-2007011389-A (MX)
Title: Methods of limiting leak off and damage in hydraulic fractures.
Inventor: HUTCHINS RICHARD D
IPC: C09K8/68
Filed: 2007-09-17
Abstract: Methods for treating a formation penetrated by a wellbore which improves fluid loss control during treatment. In some aspects, the treatments include preparing an aqueous fluid including one or more water inert polymers and an optional viscosifier, injecting the aqueous fluid into the wellbore at a pressure equal to or greater than the formation's fracture initiation pressure, and thereafter injecting into the wellbore a proppant laden fluid at a pressure equal to or greater than the formation's fracture initiation pressure. The water inert polymer may be a polymer such as an emulsion polymer or a latex polymer. Some methods of the invention use a fluid which may have a normalized leak off coefficient (Cw/sqrt(K)) equal to or less than about 0.0022, 0.0014, or 0.0010.; A conventional fluid loss additive may or may not be used in conjunction with the treatment fluid and/or the proppant laden fluid. The water inert polymer may or may not substantially enter formation pores. In another a spect, methods for reducing matrix damage to a formation during a treatment operation include preparing an aqueous treatment fluid formed of at least one water inert polymer, and injecting the fluid at a pressure equal or greater than the formation's fracture initiation pressure.
Patent MX-2007013023-A (MX)
Title: Treatment of pain.
Inventor: BRANDT MICHAEL R
IPC: A61K31/34
Filed: 2006-04-21
Abstract: This invention provides a method of treating pain in a mammal that includes administering to a mammal in need of such treatment a pain treating effective amount of a compound of the formula I: or a pharmaceutically acceptable salt thereof, wherein each of R<sub>1</sub>, R<sub>2</sub>, R<sub>3</sub>, n, y, and Ar is as defined and described herein. The present invention also provides pharmaceutical compositions for treating pain containing a pain treating effective amount of the compound of formula I.
Patent MX-2007013486-A (MX)
Title: Insulins combinations.
Inventor: MESSADEK JALLAL
IPC: A61K31/205
Filed: 2006-04-27
Abstract: A pharmaceutical association or combination comprising a therapeutic effective amount of insulin or insulin analogue, and a therapeutic effective amount of a pharmaceutically acceptable betaine, in which the insulin and the betaine possibly form a chemical entity or complex, and in which the amount of betaine is adapted for controlling the degradation and/or for increasing the duration of action and/or for enhancing the therapeutically effect of the insulin or insulin analogue.
Patent MX-2007013605-A (MX)
Title: Mono-lysine salts of azole compounds.
Inventor: PENDRI YADAGIRI R
IPC: C07C229/26
Filed: 2006-05-01
Abstract: Mono-lysine salts of triazole compounds having a secondary or tertiary hydroxy group are provided. More particularly, the new water-soluble triazole antifungal mono-lysine salt compounds, or solvates thereof, are provided having the general formula I: wherein A in formula I represents the non-hydroxy portion of a triazole antifungal compound of the type containing a secondary or tertiary hydroxyl group. R and R1 in formula I can each be a hydrogen atom or an alkyl group having one to six carbon atoms. The novel water-soluble azole compounds are useful for the treatment of fungal infections and can be administered orally, topically and parenterally.
Patent MX-2007014348-A (MX)
Title: Mechanical action estimation for washing machines.
Inventor: VAIDHYANATHAN RAVEENDRAN
IPC: D06F33/04
Filed: 2007-11-15
Abstract: An automatic clothes washer comprises a wash tub in which is disposed a wash basket defining a wash chamber for receiving fabric articles, and an article mover located within the wash chamber and driven by a motor to impart mechanical energy to the fabric articles upon contact. A method for controlling the operation of the automatic clothes washer comprises determining the work imparted to the fabric articles by the article mover, and controlling an operating cycle of the automatic washer based on the determined work.
Patent MX-2008000657-A (MX)
Title: Benzoimidazole compound capable of inhibiting prostaglandin d synthetase.
Inventor: URADE YOSHIHIRO
IPC: A61K31/501
Filed: 2006-07-12
Abstract: A benzoimidazole compound represented by the general formula (I) or a salt thereof: (I) wherein X<sup>1</sup> represents an oxygen atom or a carbonyl group; and R<sup>1</sup> represents a furan ring having 1 to 3 substituents or a pyrrole ring which may have 1 to 3 substituents, provided that a compound represented by the general formula (I) wherein the substituent is a phosphoric acid group or a phosphate ester group is excluded. The benzoimidazole compound or salt thereof has an excellent prostaglandin D synthetase inhibitory activity, and is useful as a prophylactic and/or therapeutic agent for a disease associated with prostaglandin D2 or a metabolite thereof, such as an allergic disease or an inflammatory disease or as an inhibitor for the exacerbation of Alzheimer disease or cerebral damage.
Patent MX-2008001156-A (MX)
Title: Large character set handling in limited devices.
Inventor: KAGLE JONATHAN C
IPC: G06T11/00
Filed: 2006-07-28
Abstract: Limited devices have memories that are typically too small to store a complete font having an extended character set. The ability to handle necessary characters can be provided by leveraging connectivity of a limited device to a PC or server without requiring significant bandwidth or substantially reducing performance of the limited device. The limited device stores portions a font (typically on a character-by-character basis) and downloads information from the server as needed to display characters for which the limited device does not have sufficient information.
Patent MX-2008006358-A (MX)
Title: Use of transcriptome-modifying agents and chemotherapy or radiotherapy against cancer.
Inventor: GONZALEZ ALFONSO DUENAS
IPC: C12N15/00
Filed: 2008-05-16
Abstract: The invention relates to the use of transcriptome-modifying agents in order to prevent malignant cells from undergoing the necessary genetic changes in order to combat cell insult and survive chemotherapy or radiotherapy. Said combination of transcriptome-modifying agents comprises agents that inhibit the DNA methylation machinery plus a substance that inhibits histone deacetylation. The invention relates to a treatment kit which involves the administration of an effective dose of hydralazine and valproic acid or a salt of same in the case of magnesium valproate, which is intended for use with radiotherapy or chemotherapy in the treatment of patients cancer.
Patent MX-2008009392-A (MX)
Title: Systems and methods for detecting an image of an object by use of an x-ray beam having a polychromatic distribution.
Inventor: PARHAM CHRISTOPHER A
IPC: G01N23/04
Filed: 2007-01-24
Abstract: Systems and methods for detecting an image of an object using an X-ray beam having a polychromatic energy distribution are disclosed. According to one aspect, a method can include detecting an image of an object. The method can include generating a first X-ray beam having a polychromatic energy distribution. Further, the method can include positioning a single monochromator crystal in a predetermined position to directly intercept the first X-ray beam such that a second X-ray beam having a predetermined energy level is produced. Further, an object can be positioned in the path of the second X-ray beam for transmission of the second X-ray beam through the object and emission from the object as a transmitted X-ray beam. The transmitted X-ray beam can be directed at an angle of incidence upon a crystal analyzer. Further, an image of the object can be detected from a beam diffracted from the analyzer crystal.
Patent MX-2008011667-A (MX)
Title: Piperidinyl, indolyl, pirinidyl, morpholinyl and benzimidazolyl urea derivatives as inhibitors of soluble epoxide hydrolase for the treatment of hypertension, inflammations and other diseases.
Inventor: HAMMOCK BRUCE D
IPC: C07C275/26
Filed: 2007-03-13
Abstract: Compounds of the formula (I); wherein R<sup>1</sup> is a member selected from the group consisting of C 1 -C 8 alkyl, arylC 0 -C 8 alkyl, C 3 -C 12 cycloalkyl and heterocyclyl, Y<sup>1</sup> is selected from the group consisting of a bond, C(R<sup>5</sup>) 2 , NR<sup>5</sup> and O; Y<sup>2</sup> is selected from the group consisting of a bond, NR<sup>5</sup> and O; each R<sup>2</sup>, R<sup>3</sup> and R<sup>5</sup> is independently selected from the group consisting of H, alkyl and COR<sup>6</sup>; A is heterocyclyl, optionally substituted with from 1 to 2 R<sup>7</sup> substituents; L is selected from the group consisting of a direct bond, C 1 -C 12 alkylene, C 1- C 12 heteroalkylene, C 3 -C 6 cycloalkylene, arylene, heteroarylene, -CO-, -SO in - and -Se-; R<sup>4</sup> is selected from the group consisting of H, C 1 C 8 alkyl, C 2 -C 6 alkenyl, C 2 -C 6 alkynyl, C 1 ,-C 8 heteroalkyl, arylC 0 -C 8 alkyl, C 3 C, 12 cycloalkyl and heterocyclyl, are claimed. The compounds are inhibitors of the soluble epoxide hydrolase (sEH) and useful for the treatment of hypertension, inflammation, adult respiratory distress syndrome; diabetic complications; end stage renal disease; Raynaud syndrome and arthritis.
Patent MX-2008015929-A (MX)
Title: Tampon assembly providing proper bodily placement of a pledget.
Inventor: EDGETT KEITH
IPC: A61F13/20
Filed: 2007-06-12
Abstract: Provided is a tampon applicator having one or more insertion indicators to gauge and/or control the insertion depth of a tampon. The one or more insertion indicators may be located on the tampon applicator barrel, plunger, tampon, removal string, or any combinations thereof. As a result of the one or more insertion indicators, a woman can adjust the insertion depth of the tampon to her body's requirements ensuring leakage protection, comfort, or both.
Patent MX-2008016487-A (MX)
Title: Well treating materials and methods.
Inventor: REDIGER RICHARD
IPC: E21B43/267
Filed: 2007-06-27
Abstract: The present invention is directed to an improved thermoplastic material-coated particulate composition useful for hydraulic fracturing treatments, gravel packing for sand control or other well formation treatments and especially the related methods of its use and is particularly directed to using a thermoplastic material as part of a particulate composition in a method for enhancing the stabilization of and reducing particulate flow back and fines transport in a well formation.
Patent MX-2009000368-A (MX)
Title: Indwelling catheter with anti-clotting features.
Inventor: ASH STEPHEN R
IPC: A61M25/00
Filed: 2007-07-09
Abstract: A catheter (100, 200, 300, 400) for providing blood flow includes first and second lumen parts (110, 120, 210, 220, 310, 320, 410, 420) having a distal portion (112, 212, 312, 404) with at least one port for delivering and receiving flow from a patient and a non-linear profile along the distal portion.
Patent MX-2009001145-A (MX)
Title: High speed door assembly.
Inventor: DRIFKA BRIAN NORBERT
IPC: E05F15/60
Filed: 2007-07-30
Abstract: The present invention is directed to an industrial high-speed door assembly having a reduced door panel width and having guides for guiding the door which extend into a passageway but are resilient, tough, or resiliently collapsible, to either withstand impacts from vehicle collisions or moveable during opening of the door to avoid collisions while returning for guidance upon closing the door.
Patent MX-2009002734-A (MX)
Title: Subsea actuation systems and methods.
Inventor: ALLEN DONALD WAYNE
IPC: F15D1/10
Filed: 2007-09-20
Abstract: There is disclosed a system comprising a cylinder; a piston moveable within the cylinder; an arm connected to the piston; and a mechanism for resisting movement of the piston until a predetermined pressure acts on the piston. In some embodiments, the mechanism for resisting movement comprises a shear pin connected to the arm.
Patent MX-2009002813-A (MX)
Title: Kinase inhibitors useful for the treatment of proliferative diseases.
Inventor: FLYNN DANIEL L
IPC: A61K31/519
Filed: 2007-09-13
Abstract: The present invention relates to novel kinase inhibitors and modulator compounds useful for the treatment of various diseases. More particularly, the invention is concerned with such compounds, kinase/compound adducts, methods of treating diseases, and methods of synthesis of the compounds. Preferrably, the compounds are useful for the modulation of kinase activity of Raf kinases and disease polymorphs thereof. Compounds of the present invention find utility in the treatment of mammalian cancers and especially human cancers including but not limited to malignant melanoma, colorectal cancer, ovarian cancer, papillary thyroid carcinoma, non small cell lung cancer, and mesothelioma. Compounds of the present invention also find utility in the treatment of rheumatoid arthritis and retinopathies including diabetic retinal neuropathy and macular degeneration.
Patent MX-2009003291-A (MX)
Title: Railway truck with bearing adapter.
Inventor: SCHORR RALPH H
IPC: B61F5/32
Filed: 2009-03-26
Abstract: A railway car truck is provided that includes two sideframes and a bolster. Each sideframe has a pedestal opening at each end to receive a bearing adapter assembly. The pedestal opening is formed by a roof section that includes a pad receiving opening. The bearing adapter assembly includes a cast steel bearing adapter that is formed to fit on top of a bearing assembly. An adapter pad, comprised of a selected hardness elastomer, is fit on top of the bearing adapter. The adapter pad includes a base section and a raised top section that is fit within the pad receiving opening in the pedestal roof section.
Patent MX-2009006738-A (MX)
Title: Process for reducing side-reactions during alkylene glycol and poly-alkylene glycol manufacturing.
Inventor: HOY RICHARD C
IPC: C07C29/80
Filed: 2007-12-12
Abstract: This invention relates to a process of producing one or more of an alkylene glycol or poly-alkylene glycol by the reaction of an alkylene oxide and water whereby reduced levels of undesired by products such as carbonyl compounds, ultraviolet light absorbing compounds and various metal species are produced.
Patent MX-2009007837-A (MX)
Title: Resealable container for storing moisture sensitive test elements.
Inventor: JONES EURIG WYN
IPC: G01N33/487
Filed: 2008-01-29
Abstract: A container for moisture sensitive test elements comprising a container body (2, 102, 202), an insert (22, 122, 220) fitting in container body, whereby a cavity (18, 118) is created between outer surface of insert wall (24, 124, 240) and inner surface of container body wall (4, 104, 204), and a lid (50, 150, 250) dimensioned to seal container open end when in a closed position, wherein a desiccant material is contained within the cavity (18, 118) between container body wall and insert wall. Insert wall defines a hollow channel (29, 129, 229) which is dimensioned that at least one test element extents from the insert channel facilitating accessibility to an individual test element for the testing of an analyte of interest. Desiccant material includes an indicator whose colour changes when exposed to moisture indicating to a user whether contents therein, i.e. test elements, have been compromised by environmental factors.
Patent MX-2009009553-A (MX)
Title: Intravaginal device of anatomic and collapsible design for the self sampling and containment of epithelial cells from the cervix.
Inventor: MENDEZ RAMSES GALAZ
IPC: A61F5/00
Filed: 2009-08-28
Abstract: Described is a device for allowing women to collect and preserve samples of cervical cells for their subsequent study in a lab of clinical analysis. The invention includes a cylindrical body made of a transparent and flexible material, which is known as insertion (13) and cellular contention device, which houses a central stem (11) intended to push and retract, in an axial manner, a cell collector (2) with special characteristics, which is assembled in the proximal end portion thereof. The insertion of the device is self-induced by the woman, thereby having morphological characteristics adapted to the anatomical shape of the vagina. The central stem (11) is slid into the inner portion of the insertion device for positioning the cell collector (2) in the cervix surface; once the sample is taken, the central stem (11) is retracted, and the cell collector (2) is collapsed due to the sliding action performed towards the inner portion of the insertion device (13), thus reaching the distal end of the same, and being placed in the inner portion of the handle (14), which may include a liquid medium for containing cells, the device being sealed by a check valve of the membrane type at the proximal portion and a stopper with an aperture located at the distal portion thereof, which avoids leakages of the liquid.
Patent MX-2010001523-A (MX)
Title: Sealant compositions and methods of use.
Inventor: LENDE GUNNAR
IPC: C09K8/62
Filed: 2008-08-05
Abstract: A composition comprises an aqueous fluid, fly ash, fume silica, and a filler material, wherein the composition is a cohesive sealant. In one embodiment, the sealant composition comprises a base fluid, a binder material, and a filler material, wherein: the binder material comprises at least one material selected from the group consisting of fly ash, hydrated lime, fume silica, a pozzolanic material, a cementitious material, and any derivative thereof; and the sealant composition will form a cohesive sealant. A method of sealing in a wellbore comprises introducing a sealant composition into a well bore that penetrates a subterranean formation, wherein the sealant composition comprises a base fluid, a binder material, and a filler material; and allowing the sealant composition to form a cohesive sealant.
Patent MX-2010002015-A (MX)
Title: Methods, apparatuses, system, and related computer program product for user equipment access.
Inventor: RAESAENEN JUHA A
IPC: H04L29/12
Filed: 2008-07-28
Abstract: It is disclosed a method comprising holding access information relating to a terminal and a first network entity external to a currently visited network of the terminal, the access information being associated with a first network plane below a second network plane relating to network session initiation, and signalling, based on the second network plane, the held access information to a controlling entity; a method comprising receiving the signaled access information, the receiving being performed based on the second network plane, and relaying, based on the second network plane, the received access information to a second network entity; and a method comprising receiving the relayed access information, the receiving being performed based on the second network plane, and configuring the first network plane based on the access information.
Patent MX-2010002339-A (MX)
Title: Catalysis of viscoelastic foams with bismuth salts.
Inventor: CASATI FRANCOIS
IPC: C08G18/22
Filed: 2008-08-26
Abstract: The embodiments of the present invention provide for viscoelastic polyurethane foams made in the presence of a bismuth comprising catalyst. The viscoelastic polyurethane foam may be the reaction product of a reaction mixture including at least one polyol and at least one isocyanate, wherein the at least one polyol and the at least one isocyanate are reacted in the presence of at least one bismuth comprising catalyst, and wherein the viscoelastic polyurethane foam has a density of less than 100 kg/m<sup>3</sup> and a resilience of less than about 25%.
Patent MX-2010004531-A (MX)
Title: Salts of 2-iodo-n-[(4-methoxy-6-methyl-1,3,5-triazine-2-yl)carbam oyl]benzenesulfonamide, method for the production thereof and use thereof as herbicides and plant growth regulators.
Inventor: FEUCHT DIETER
IPC: A01N47/36
Filed: 2008-10-22
Abstract: The invention relates to salts of 2-iodo-N-[(4-methoxy-6-methyl-1,3,5-triazine-2- yl)carbamoyl]benzenesulfonamide, to methods for the production thereof, and use thereof as herbicides, in particular as herbicides for selectively combating undesired harmful plants in useful plant cultures, permanent crops or uncultivated land, and as plant growth regulators, by themselves, or with safeners and/or combined with other herbicides, use thereof for combating undesired harmful plants (such as unwanted grasses and weeds) in specific plant cultures or as plant protection regulators, with simultaneous and/or sequential use, either as a finished formulation or as a tank mix.